{
    "clinical_study": {
        "@rank": "65327", 
        "arm_group": [
            {
                "arm_group_label": "Methylprednisolone", 
                "arm_group_type": "Active Comparator", 
                "description": "Methylprednisolone i.v. 15mg/kg x 1 intraoperative"
            }, 
            {
                "arm_group_label": "Placebo (NaCl)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo i.v., x1, intraoperative"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate if methylprednisolone is effective in reducing\n      the cerebral inflammatory response after open heart surgery with cardiopulmonary bypass."
        }, 
        "brief_title": "Effect of Steroids on Cerebrospinal Fluid Markers of Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement", 
        "condition": "Aortic Stenosis", 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Stenosis", 
                "Inflammation"
            ]
        }, 
        "detailed_description": {
            "textblock": "In a previous study we found that patients undergoing aortic valve surgery had elevated\n      cerebrospinal inflammatory markers. In this study we aim to investigate if this inflammatory\n      response can be reduced after treatment with steroids.\n\n      20 patients will be randomized to intraoperative treatment with either placebo or\n      methylprednisolone 15mg/kg. CSF and blood will be collected the day before and the day after\n      surgery, analyzed for markers of inflammation (IL-6, IL-8), neuronal damage (S-100) and\n      blood brain barrier function (alb)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective aortic surgery +/- coronary artery bypass grafting (CABG)\n\n        Exclusion Criteria:\n\n          -  coagulopathy\n\n          -  preoperative neurologic deficit\n\n          -  uncontrolled hypertension"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01755338", 
            "org_study_id": "2012-004232-37"
        }, 
        "intervention": {
            "arm_group_label": "Methylprednisolone", 
            "description": "15mg/kg i.v.", 
            "intervention_name": "methylprednisolone", 
            "intervention_type": "Drug", 
            "other_name": "Solu Medrol"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cerebrospinal fluid", 
            "inflammatory markers", 
            "heart surgery", 
            "neuronal damage", 
            "blood brain barrier"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "contact": {
                "email": "mattias.danielsson@vgregion.se", 
                "last_name": "Mattias Danielson, MD", 
                "phone": "+46313427452"
            }, 
            "facility": {
                "address": {
                    "city": "G\u00f6teborg", 
                    "country": "Sweden", 
                    "state": "VGR", 
                    "zip": "41345"
                }, 
                "name": "Sahlgrenska University Hospital"
            }, 
            "investigator": {
                "last_name": "Mattias Danielson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Steroids on Cerebrospinal Fluid Markers of Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement", 
        "overall_contact": {
            "email": "mattias.danielsson@vgregion.se", 
            "last_name": "Mattias Danielson, MD", 
            "phone": "+46313427452"
        }, 
        "overall_contact_backup": {
            "email": "sven-erik.ricksten@aniv.gu.se", 
            "last_name": "Sven Erik Ricksten, Professor", 
            "phone": "+46313427433"
        }, 
        "overall_official": {
            "affiliation": "Sahlgrenska University Hospital, Sweden", 
            "last_name": "Sven-Erik Ricksten, Professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Swedish Research Council", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Changes in cerebrospinal fluid (CSF) levels of IL-6, IL-8, S100B, alb", 
            "safety_issue": "No", 
            "time_frame": "24h after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01755338"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sahlgrenska University Hospital, Sweden", 
            "investigator_full_name": "Mattias Danielson", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Postoperative/intraoperative insulin demand", 
            "safety_issue": "No", 
            "time_frame": "24h after surgery"
        }, 
        "source": "Sahlgrenska University Hospital, Sweden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sahlgrenska University Hospital, Sweden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}